This site displays a prototype of a “Web 2.0” version of the daily
Federal Register. It is not an official legal edition of the Federal
Register, and does not replace the official print version or the official
electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal
Register documents. Each document posted on the site includes a link to the
corresponding official PDF file on govinfo.gov. This prototype edition of the
daily Federal Register on FederalRegister.gov will remain an unofficial
informational resource until the Administrative Committee of the Federal
Register (ACFR) issues a regulation granting it official legal status.
For complete information about, and access to, our official publications
and services, go to
About the Federal Register
on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable
regulatory information on FederalRegister.gov with the objective of
establishing the XML-based Federal Register as an ACFR-sanctioned
publication in the future. While every effort has been made to ensure that
the material on FederalRegister.gov is accurately displayed, consistent with
the official SGML-based PDF version on govinfo.gov, those relying on it for
legal research should verify their results against an official edition of
the Federal Register. Until the ACFR grants it official status, the XML
rendition of the daily Federal Register on FederalRegister.gov does not
provide legal notice to the public or judicial notice to the courts.
Notice
Enter a search term or FR citation e.g.
88 FR 38230 FR 78782024-13208USDA09/05/24RULE0503-AA39SORN
Choosing an item from
full text search results
will bring you to those results. Pressing enter in the search box
will also bring you to search results.
Choosing an item from
suggestions
will bring you directly to the content.
Comments, identified by docket identification (ID) number EPA- HQ-OPP-2020-0514 must be received on or before February 19, 2021.
Table of Contents
Enhanced Content - Table of Contents
This table of contents is a navigational tool, processed from the
headings within the legal text of Federal Register documents.
This repetition of headings to form internal navigation links
has no substantive legal effect.
Comments are no longer being accepted.
See DATES for details.
5,280 comments have
been received at Regulations.gov.
Agencies review all submissions and may choose to redact, or withhold,
certain submissions (or portions thereof). Submitted comments may not be
available to be read until the agency has approved them.
Docket Title
Document ID
Comments
National Level Threatened and Endangered Species Biological Evaluations for Atrazine, Simazine, and Propazine
FederalRegister.gov retrieves relevant information about this document
from Regulations.gov to provide users with additional context. This
information is not part of the official Federal Register document.
National Level Threatened and Endangered Species Biological Evaluations for Atrazine, Simazine, and Propazine
Document page views are updated periodically throughout the day and are
cumulative counts for this document. Counts are subject to sampling,
reprocessing and revision (up or down) throughout the day.
Page views
222
as of
06/08/2026 at 4:15 pm EDT
Other Formats
Enhanced Content - Other Formats
This document is also available in the following formats:
This PDF is FR Doc. 2020-28828 as it appeared on Public Inspection on
12/29/2020 at 8:45 am.
It was viewed
13
times while on Public Inspection.
If you are using public inspection listings for legal research, you
should verify the contents of the documents against a final, official
edition of the Federal Register. Only official editions of the
Federal Register provide legal notice of publication to the public and judicial notice
to the courts under 44 U.S.C. 1503 & 1507.
Learn more here.
Published Document: 2020-28828 (85 FR 86556)
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
AGENCY:
Environmental Protection Agency (EPA).
ACTION:
Notice; extension of comment period.
SUMMARY:
EPA issued a notice in the
Federal Register
of November 6, 2020, opening a 60-day comment period on the draft nationwide biological evaluations for the registration review of the pesticides atrazine, simazine, and propazine relative to the potential effects on threatened and endangered species and their designated critical habitats. This document extends the comment period for 45 days, from January 5, 2021 to February 19, 2021.
DATES:
Comments, identified by docket identification (ID) number EPA-HQ-OPP-2020-0514 must be received on or before February 19, 2021.
ADDRESSES:
Follow the detailed instructions provided under
ADDRESSES
in the
Federal Register
document of November 6, 2020 (85 FR 71071) (FRL-10015-77).
This document extends the public comment period established in the
Federal Register
document of November 6, 2020 (85 FR 71071) (FRL-10015-77), which opened a 60-day public comment period for the draft nationwide biological evaluations for the registration review of the pesticides atrazine, simazine, and propazine relative to the potential effects on threatened and endangered species and their designated critical habitats. As noted in that document, the schedule for conducting the atrazine and simazine biological evaluations was negotiated as part of a partial settlement agreement pursuant to a joint
( printed page 86557)
stipulation filed on October 18, 2019 and entered by the court on October 22, 2019, in
Center for Biological Diversity et al.
v.
EPA et al.
(N.D. Ca) (3:11-cv-00293). EPA stated in this settlement that it would also include propazine in this group of effects determinations. EPA is hereby extending the public comment period, which was set to end on January 5, 2021, to February 19, 2021.
After considering a number of requests to extend the comment period received from various stakeholders, EPA is extending the comment period for the following reasons: (1) The length, complexity, and highly technical nature of the draft biological evaluations; (2) the need for some stakeholders to engage experts familiar with the subject matter to assist them with providing comments; (3) the large number of stakeholders potentially impacted by the draft biological evaluations; (4) the importance of soliciting feedback from stakeholders who may be affected; and (5) the stakeholders' need for additional time to review and develop constructive comments for these complex and lengthy documents.
To submit comments, or access the docket, please follow the detailed instructions provided under
ADDRESSES
in the
Federal Register
document of November 6, 2020. If you have any questions regarding the applicability of this action to a particular entity, consult the person listed under
FOR FURTHER INFORMATION CONTACT
.
5,280 comments have been received at Regulations.gov.
Agencies review all submissions and may choose to redact, or withhold, certain submissions (or portions thereof). Submitted comments may not be available to be read until the agency has approved them.